Gurmeet Chadha's top 3 bets from auto and auto ancillaries
«I think the patient realisation has also gone up. It is nearing almost per patient to about 800 bucks or something and I think there is a lot of unorganised market here,» says Gurmeet Chadha, Complete Circle Consultants.
Within pharma and healthcare which are your top recommendations?
So, we again are tracking diagnostics. Initially, we had issues when the disruption happened by the new-age companies.
I think consolidation is coming back to stronger names. So, we tracked Dr Lal while Q1 was a little soft because of a bit of seasonality but they continue to improve on the test mix as well as the new distribution reach as they are setting up both in terms of collection centres as well as the super speciality test. I think the patient realisation has also gone up.
It is nearing almost per patient to about 800 bucks or something and I think there is a lot of unorganised market here.
So, we probably see some movement also which we call informal to formal over a period of time, so that is something we are tracking now.
Hospital space we like but it is just that the stocks have just run up too quickly and as I said, in hotels, even in hospitals again the capital allocation has improved significantly. So, for example, Max is only focussed on Delhi, Mumbai, largely metros.
And Narayana Hrudayalaya again is more in tier II towns and then we like one name, which is into child paediatric care which is Rainbow. So, we are tracking them.
But valuation wise, again, not much comfort in these markets.
Bajaj Finance continues to be your favourite there. You talked about Jio Financial as well. But let us say from the micro finance, from the other select NBFCs, any other name that you would want to recommend?
So, we like the affordable housing
